Invitation - Presentation of Sobi's first quarter results 2013
(Thomson Reuters ONE) -
On April 26, at 08:00 CET, Swedish Orphan Biovitrum AB (Sobi) will publish its
interim report for the first quarter, 2013.
Financial analysts and media are invited to participate in a telephone
conference, which will include a presentation of the results, at 14:00 CET. The
event will be hosted by Sobi's CEO and President, Geoffrey McDonough, and the
presentation will be held in English.
The presentation can be followed live or afterwards on our website,
www.sobi.com. Slides used in the presentation will be made available on our
website prior to the telephone conference.
To participate in the telephone conference, please call:
SE: +46 8 5199 9366
US: +1 877 788 9023
UK: +44 207 660 2078
Audience URL:
https://www.anywhereconference.com/?Conference=137346811&PIN=479968
---
About Sobi
Sobi is an international specialty healthcare company dedicated to rare
diseases. Our mission is to develop and deliver innovative therapies and
services to improve the lives of patients. The product portfolio is primarily
focused on inflammation and genetic diseases, with three late stage biological
development projects within hemophilia and neonatology. We also market a
portfolio of specialty and rare disease products for partner companies. Sobi is
a pioneer in biotechnology with world-class capabilities in protein biochemistry
and biologics manufacturing. In 2012, Sobi had total revenues of SEK 1.9 billion
(? 215 M) and about 480 employees. The share (STO: SOBI) is listed on NASDAQ OMX
Stockholm. More information is available at www.sobi.com
For more information - not for publication
Media relations Investor relations
Oskar Bosson, Head of Communications Jörgen Winroth, Vice President, Head of
Investor Relations
T: +46 70 410 71 80 T: +46 8 697 20 00
oskar.bosson(at)sobi.com jorgen.winroth(at)sobi.com
Sobi press release April 17, 2013 in pdf version:
http://hugin.info/134557/R/1693436/556622.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Swedish Orphan Biovitrum AB (publ) via Thomson Reuters ONE
[HUG#1693436]
Unternehmensinformation / Kurzprofil:
Datum: 17.04.2013 - 08:30 Uhr
Sprache: Deutsch
News-ID 249821
Anzahl Zeichen: 2868
contact information:
Town:
Stockholm
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 178 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Invitation - Presentation of Sobi's first quarter results 2013"
steht unter der journalistisch-redaktionellen Verantwortung von
Swedish Orphan Biovitrum AB (publ) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
